Ethical issues in early diagnosis and prevention of Alzheimer disease.

Ethical issues in early diagnosis and prevention of Alzheimer disease. Dialogues Clin Neurosci. 2019 Mar;21(1):101-108 Authors: Whitehouse PJ Abstract This paper considers ethical issues related to early diagnosis and all forms of prevention of Alzheimer disease and related conditions. It offers a critical view of the current state of scientific, clinical, and social responses to the growing number of older people with cognitive challenges, and suggests how priorities going forward should be different from those receiving most attention today. We begin with a review of global policy efforts, consider the fundamental goals of prevention, examine issues surrounding early diagnosis, explore more deeply values associated with efforts to prevent age associated cognitive decline, and conclude by considering often unexplored ethical issues that contextualize the field and should influence our approaches to the future. PMID: 31607785 [PubMed - in process]
Source: Dialogues in Clinical Neuroscience - Category: Neuroscience Tags: Dialogues Clin Neurosci Source Type: research

Related Links:

Publication date: 18 January 2020Source: New Scientist, Volume 245, Issue 3265Author(s): Alice Klein
Source: New Scientist - Category: Science Source Type: research
DEMENTIA is a progressive neurological condition that mainly affects people over the of 65, although it is not a natural part of ageing. Spotting the early warning signs is key to maintaining quality of life for as long as possible. A recent study suggests that Alzheimer ’s disease, the most common form of dementia, can be signalled by a change in your eyes.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Herring WJ, Ceesay P, Snyder E, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D Abstract INTRODUCTION: We evaluated the clinical profile of the orexin receptor antagonist suvorexant for treating insomnia in patients with mild-to-moderate probable Alzheimer's disease (AD) dementia. METHODS: Randomized, double-blind, 4-week trial of suvorexant 10 mg (could be increased to 20 mg based on clinical response) or placebo in patients who met clinical diagnostic criteria for both probable AD dementia and insomnia. Sleep was assessed by overnight polysomnography in a sleep laboratory. The primar...
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
Authors: Fossel M PMID: 31943780 [PubMed - as supplied by publisher]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
.
Source: Journal of the American College of Nutrition - Category: Nutrition Authors: Source Type: research
The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.
Source: Acta Neuropathologica - Category: Neurology Source Type: research
ConclusionThese results demonstrate that vortioxetine may improve cognitive impairment in 5 ×FAD mice. The role in cognitive improvement may be related to the beneficial effects of vortioxetine on synaptic function.
Source: Psychopharmacology - Category: Psychiatry Source Type: research
CONCLUSIONS: ¹⁸F-FC119S PET provides high sensitivity and specificity in detecting AD and therefore may be considered a useful diagnostic tool for AD. PMID: 31942769 [PubMed]
Source: Journal of Clinical Neurology - Category: Neurology Tags: J Clin Neurol Source Type: research
Publication date: Available online 17 January 2020Source: Life SciencesAuthor(s): Hongmei Wang, Ting Zhang, Xuhua Ge, Jingjiong Chen, Yuwu Zhao, Jianliang FuAbstractAimsMitochondrial dysfunction is an early prominent feature of Alzheimer's disease (AD). In the present study, we sought to investigate whether defective mitophagy is tightly related to amyloid-β (Aβ)-induced mitochondrial dysfunction.Main methodsImmunofluorescence, western blot and transmission electron microscopy were used to examine mitophagy. Mitochondrial membrane potential was assessed using the JC-1 dye. Mitochondrial ROS was detected using Mit...
Source: Life Sciences - Category: Biology Source Type: research
Chem. Commun., 2020, Advance Article DOI: 10.1039/C9CC09233A, CommunicationGuanglei Lv, Anyang Sun, Minqi Wang, Peng Wei, Ruohan Li, Tao Yi Detection of A β protofibrils at the early stage of Alzheimer's disease was realized by a novel near-infrared probe (DCM-AN) based on dicyanomethylene-4H-pyran. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
More News: Alzheimer's | Brain | Medical Ethics | Neurology | Neuroscience